Oncolytics Biotech Inc. (ONC.TO)
CAD 1.1
(-2.65%)
CAD 1.1
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.44 Million | -23.35 Million | -22.43 Million | -22.06 Million | -19.9 Million | -11.92 Million |
| Net Income | -27.75 Million | -24.83 Million | -26.3 Million | -22.5 Million | -33.12 Million | -17.03 Million |
| Depreciation & Amortization | 403 Thousand | 392 Thousand | 452.06 Thousand | 446.18 Thousand | 485.57 Thousand | 95.37 Thousand |
| Deferred income taxes | -2.36 Million | - | 408.56 Thousand | -2.84 Million | 12.96 Million | -374.33 Thousand |
| Stock-based compensation | 2.06 Million | 2.37 Million | 3.82 Million | 2.55 Million | 1.47 Million | 1.41 Million |
| Change in working capital | 1.76 Million | 391 Thousand | -907.98 Thousand | 209.77 Thousand | -1.79 Million | 3.9 Million |
| Other non-cash items | -2.56 Million | -1.68 Million | 91.72 Thousand | 68.52 Thousand | 94.81 Thousand | 75.77 Thousand |
| Investing Cash Flow | 20.22 Million | -20.4 Million | -285.94 Thousand | -29.3 Thousand | -10.9 Thousand | -107.46 Thousand |
| Investments in PPE | -8000.00 | -55 Thousand | -285.94 Thousand | -29.3 Thousand | -10.9 Thousand | -107.46 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -20.34 Million | - | - | - | - |
| Sales/Maturities of investments | 20.23 Million | - | - | - | - | - |
| Other Investing Activities | 20.23 Thousand | -20.34 Thousand | - | - | - | - |
| Financing Cash Flow | 31.99 Million | 12.2 Million | 33.01 Million | 39.77 Million | 21.01 Million | 13.29 Million |
| Debt repayment | -407 Thousand | -381 Thousand | -365.51 Thousand | -460.72 Thousand | -447.49 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 32.4 Million | 12.57 Million | 32.91 Million | 38.29 Million | 17.99 Million | 13.17 Million |
| Other Financing Activities | 32.4 Thousand | 12 Thousand | 469.39 Thousand | 1.93 Million | 3.46 Million | 124.95 Thousand |
| Accounts receivables | 506 Thousand | 345 Thousand | -776.39 Thousand | 1.97 Million | -2.01 Million | 4.76 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.25 Million | 46 Thousand | -131.59 Thousand | -1.76 Million | 221.34 Thousand | -862.76 Thousand |
| Cash at beginning of period | 9.5 Million | 41.26 Million | 31.21 Million | 14.14 Million | 13.69 Million | 11.83 Million |
| Cash at end of period | 31.53 Million | 11.66 Million | 41.26 Million | 31.21 Million | 14.14 Million | 13.69 Million |
| Capital Expenditure | -8000.00 | -55 Thousand | -285.94 Thousand | -29.3 Thousand | -10.9 Thousand | -107.46 Thousand |
| Effect of forex changes on cash | -522 Thousand | 1.95 Million | -253.25 Thousand | -604.5 Thousand | -650.42 Thousand | 592.33 Thousand |
| Net cash flow / Change in cash | 22.03 Million | -29.59 Million | 10.04 Million | 17.07 Million | 448.14 Thousand | 1.86 Million |
| Free Cash Flow | -28.45 Million | -23.41 Million | -22.71 Million | -22.09 Million | -19.91 Million | -12.02 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7256.00 | -6.89 Million | -3.94 Million | -27.75 Million | -9.92 Million | -7.44 Million |
| Depreciation & Amortization | 98.00 | 123 Thousand | 107 Thousand | 403 Thousand | 103 Thousand | 96 Thousand |
| Deferred income taxes | - | - | -358 Thousand | -2.36 Million | -707 Thousand | 444 Thousand |
| Stock-based compensation | 506.00 | 576 Thousand | 759 Thousand | 2.06 Million | 750 Thousand | 242 Thousand |
| Change in working capital | -828.00 | -33 Thousand | 1.52 Million | 1.76 Million | 3.67 Million | -1.88 Million |
| Other non-cash items | 661.00 | -332 Thousand | -4.2 Million | -2.56 Million | 74 Thousand | 75 Thousand |
| Investing Cash Flow | -155.00 | -46 Thousand | -3000.00 | 20.22 Million | 6.76 Million | 6.79 Million |
| Investments in PPE | -155.00 | -46 Thousand | -3000.00 | -8000.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 20.23 Million | 6.76 Million | 6.79 Million |
| Other Investing Activities | - | - | - | 20.23 Thousand | 6766.00 | 6790.00 |
| Financing Cash Flow | 1975.00 | 1.49 Million | 1.74 Million | 31.99 Million | 21.28 Million | 3.69 Million |
| Debt repayment | -65.00 | -103 Thousand | -104 Thousand | -407 Thousand | -102 Thousand | -100 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -882.00 | - | - | - |
| Common Stock Issuance | 2.04 Million | 1.59 Million | 1.84 Million | 32.4 Million | 21.32 Million | 3.44 Million |
| Other Financing Activities | 2040.00 | 1598.00 | 2728.00 | 32.4 Thousand | 63 Thousand | 343 Thousand |
| Accounts receivables | -1469.00 | -87 Thousand | 615 Thousand | 506 Thousand | -71 Thousand | 171 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 641.00 | 54 Thousand | 911 Thousand | 1.25 Million | 3.74 Million | -2.05 Million |
| Cash at beginning of period | 29.6 Thousand | 31.53 Million | 36.25 Million | 9.5 Million | 17.52 Million | 15.87 Million |
| Cash at end of period | 24.85 Thousand | 27.23 Million | 31.53 Million | 31.53 Million | 39.98 Million | 17.52 Million |
| Capital Expenditure | -155.00 | -46 Thousand | -3000.00 | -8000.00 | - | - |
| Effect of forex changes on cash | 246.00 | 711 Thousand | -684 Thousand | -522 Thousand | 436 Thousand | -369 Thousand |
| Net cash flow / Change in cash | -4753.00 | -4.3 Million | -4.72 Million | 22.03 Million | 22.46 Million | 1.64 Million |
| Free Cash Flow | -6974.00 | -7.51 Million | -6.12 Million | -28.45 Million | -6.03 Million | -8.46 Million |
CYBN
NUVSF
NGRRF
ALKEF
HPQFF
ACT